Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
CALL
QuantumScape Corp
QS
$3.81B
| $4.4M | ﹤0.01% |
512,700
-492,100
| -49% | -$6.57M |
|
3952
Rigel Pharmaceuticals
RIGL
$795M
| $4.4M | ﹤0.01% |
389,748
-7,053
| -2% | -$142K |
|
3953
iShares MSCI BIC ETF
BKF
$76.5M
| $4.4M | ﹤0.01% |
119,131
+34,620
| +41% | +$1.26M |
|
3954
PUT
Acadia Pharmaceuticals
ACAD
$4.87B
| $4.4M | ﹤0.01% |
312,400
+243,100
| +351% | +$4.54M |
|
3955
Coeur Mining
CDE
$19.3B
| $4.4M | ﹤0.01% |
1,447,995
+316,966
| +28% | +$1.25M |
|
3956
PUT
First Citizens BancShares
FCNCA
$25.9B
| $4.4M | ﹤0.01% |
6,730
-4,606
| -41% | -$3M |
|
3957
CALL
Legend Biotech
LEGN
$3.95B
| $4.4M | ﹤0.01% |
80,000
+47,400
| +145% | +$2M |
|
|
FTCH
3958
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $4.4M | ﹤0.01% |
614,100
-436,800
| -42% | -$4.47M |
|
|
WNS
3959
DELISTED
WNS Holdings
WNS
| $4.39M | ﹤0.01% |
58,873
+16,344
| +38% | +$1.25M |
|
3960
First Majestic Silver
AG
$9.49B
| $4.39M | ﹤0.01% |
611,896
-209,081
| -25% | -$2.04M |
|
|
MPT
3961
PUT
Medical Properties Trust
MPT
$2.5B
| $4.39M | ﹤0.01% |
287,500
+102,000
| +55% | +$1.84M |
|
3962
Materion
MTRN
$5.9B
| $4.39M | ﹤0.01% |
59,500
+14,297
| +32% | +$1.15M |
|
3963
CALL
Huntington Bancshares
HBAN
$36.2B
| $4.38M | ﹤0.01% |
364,400
-32,100
| -8% | -$426K |
|
3964
CALL
Plains All American Pipeline
PAA
$16.9B
| $4.38M | ﹤0.01% |
446,400
-86,500
| -16% | -$938K |
|
3965
Coursera
COUR
$1.53B
| $4.38M | ﹤0.01% |
308,635
-66,920
| -18% | -$1.19M |
|
3966
CALL
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.3B
| $4.37M | ﹤0.01% |
250,400
+4,400
| +2% | +$82.9K |
|
3967
PUT
Schwab US Dividend Equity ETF
SCHD
$108B
| $4.37M | ﹤0.01% |
183,000
-51,300
| -22% | -$1.31M |
|
3968
Vanguard Russell 2000 Value ETF
VTWV
$1.38B
| $4.37M | ﹤0.01% |
36,642
+23,017
| +169% | +$3M |
|
3969
The Ensign Group
ENSG
$10.6B
| $4.36M | ﹤0.01% |
59,372
+1,836
| +3% | +$147K |
|
|
LOVE
3970
PUT
LoveSac
LOVE
$253M
| $4.36M | ﹤0.01% |
158,600
+90,700
| +134% | +$3.53M |
|
3971
CALL
PureCycle Technologies
PCT
$1.4B
| $4.36M | ﹤0.01% |
587,900
-46,300
| -7% | -$388K |
|
3972
CVR Partners
UAN
$1.31B
| $4.36M | ﹤0.01% |
43,651
+41,531
| +1,959% | +$5.58M |
|
3973
CALL
Voya Financial
VOYA
$9.2B
| $4.36M | ﹤0.01% |
73,200
+20,700
| +39% | +$1.33M |
|
3974
CALL
Spectrum Brands
SPB
$2.07B
| $4.36M | ﹤0.01% |
53,100
+15,100
| +40% | +$1.3M |
|
3975
CALL
Public Service Enterprise Group
PEG
$37.9B
| $4.35M | ﹤0.01% |
68,800
+24,400
| +55% | +$1.66M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.